jobs

AstraZeneca CEO Soriot may stay after all

July 17, 2017

Soriot to host results announcement as usual

AstraZeneca CEO Soriot may stay after all

https://pharmaphorum.com/news/astrazeneca-ceo-soriot-may-stay/

AZ CEO set to take charge at Teva – report

July 13, 2017

Report raises concerns about outcome of MYSTIC trial.

AZ CEO set to take charge at Teva – report

https://pharmaphorum.com/news/az-ceo-teva/

After missing out on CEO job, Novo’s US head quits

March 1, 2017

The pressure on Novo Nordisk’s diabetes portfolio is mounting in the US – and the situation seems even

After missing out on CEO job, Novo’s US head quits

https://pharmaphorum.com/news/missing-ceo-job-novos-us-head-quits/

GSK hires AZ’s Miels to lead pharma division

January 19, 2017

New CEO poaches Luke Miels from rival

GSK hires AZ’s Miels to lead pharma division

https://pharmaphorum.com/news/gsk-hires-azs-miels-lead-pharma-division/

Ex-Baxalta David Meek named as new chief at Ipsen

July 12, 2016

Meek will replace Marc de Garidel.

Ex-Baxalta David Meek named as new chief at Ipsen

https://pharmaphorum.com/news/david-meek-appointed-ceo-ipsen/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

jobs

AstraZeneca CEO Soriot may stay after all

AZ CEO set to take charge at Teva – report

After missing out on CEO job, Novo’s US head quits

GSK hires AZ’s Miels to lead pharma division

Ex-Baxalta David Meek named as new chief at Ipsen

Inhalation and Respiratory Drug Products Summit

THET Annual Conference 2017

Clinical Trial Supply East Coast 2017

Livongo’s diabetes solution impresses in latest study

Vifor’s hyperkalaemia drug Veltassa approved in Europe

New 3-year data supports Kite ‘cure’ hopes for CAR-T

Daiichi Sankyo anticoagulant gains EU label boost

Teva’s Cinqaero to challenge Nucala after clearing NICE

The most notable digital health trends of 2017 so far

Europe has untapped medical innovation – but needs high speed connections to make it work

Healthcare’s hype cycle: which technologies will stay the course?

Looking back, looking forward – Janssen’s 60 years on the psychiatry horizon

What HCPs say about Roche’s breast cancer drug

Search

Advanced Search

Trending

jobs